New oral anticoagulants in severe trauma patients: Enemy at the gates?

被引:5
|
作者
Egea-Guerrero, J. J. [1 ,2 ]
Quintana Diaz, M. [3 ,4 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Neurocrit, Unidad Gest Clin Cuidados Crit & Urgencias, Seville, Spain
[2] Univ Seville, CSIC, Inst Biomed Sevilla IBiS, Seville, Spain
[3] Hosp Univ La Paz, IdiPAZ, Dept Urgencias, Madrid, Spain
[4] Hosp Univ La Paz, IdiPAZ, Unidad Cuidados Intens, Madrid, Spain
关键词
New oral anticoagulants; Trauma; Bleeding; Reversion; Prothrombin complex Concentrate; DABIGATRAN ETEXILATE; ATRIAL-FIBRILLATION; WARFARIN; REVERSAL; MANAGEMENT; METAANALYSIS; RIVAROXABAN; ANTIDOTE; SAFETY;
D O I
10.1016/j.medin.2014.09.008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The high incidence of trauma, especially in elderly people anticoagulated with new oral anticoagulants (NOAs), has become a major challenge, particularly in critical situations with Life-threatening bleeding. Under these circumstances, urgent NOA reversion becomes mandatory. Prothrombin complex has become a frequent indication in critical situations in which rapid reversal of anticoagulation is needed and where the use of fresh frozen plasma is limited. This study offers our point of view regarding the usefulness of NOAs, not only in the prevention of cardioembolic events but also as regards their emergent reversion in cases of severe bleeding associated to trauma. (C) 2014 Elsevier Espana, S.L.U. and SEMICYUC. All rights reserved.
引用
收藏
页码:167 / 171
页数:5
相关论文
共 50 条
  • [41] Reversal strategies in patients treated with direct oral anticoagulants
    Gressenberger, Paul
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (05) : 389 - 392
  • [42] Management of hemorrhage in patients treated with direct oral anticoagulants
    Grottke, O.
    Lier, H.
    Hofer, S.
    ANAESTHESIST, 2017, 66 (09): : 679 - 689
  • [43] Impact of Direct Oral Anticoagulants in Patients With Hip Fractures
    Bruckbauer, Martin
    Prexl, Oliver
    Voelckel, Wolfgang
    Ziegler, Bernhard
    Grottke, Oliver
    Maegele, Marc
    Schoechl, Herbert
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2019, 33 (01) : E8 - E13
  • [44] Reversal of novel oral anticoagulants in patients with major bleeding
    Siegal, Deborah M.
    Cuker, Adam
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (03) : 391 - 398
  • [45] Intracranial haemorrhage in patients treated with direct oral anticoagulants
    Beynon, Christopher
    Sakowitz, Oliver W.
    Stoerzinger, Dominic
    Orakcioglu, Berk
    Radbruch, Alexander
    Potzy, Anna
    Unterberg, Andreas W.
    THROMBOSIS RESEARCH, 2015, 136 (03) : 560 - 565
  • [46] Stroke Prevention in Patients With Atrial Fibrillation: Focus on New Oral Anticoagulants
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2013, 125 (03) : 155 - 161
  • [47] New oral anticoagulants from the perspective of trauma surgery
    Siebenlist, S.
    Haas, S.
    Elser, F.
    Stoeckle, U.
    UNFALLCHIRURG, 2010, 113 (11): : 886 - 892
  • [48] Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants
    Wharin, Caitlin
    Tagalakis, Vicky
    BLOOD REVIEWS, 2014, 28 (01) : 1 - 8
  • [49] Perioperative management of trauma surgery patients treated with direct oral anticoagulants
    Henze, Larissa
    Sckell, Axel
    Maerz, Alexander
    Junghanss, Christian
    UNFALLCHIRURG, 2019, 122 (08): : 633 - 645
  • [50] General characteristics of the new oral anticoagulants
    Gegu, Marine
    Chevalet, Pascal
    Piloquet, Francois-Xavier
    Berrut, Gilles
    De Decker, Laure
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2013, 11 : 4 - 9